Results
|
|
21.
|
|
|
|
22.
|
Phase 2 trial of sunitinib and gemcitabine in patients with sarcomatoid and/or poor-risk metastatic renal cell carcinoma. Michaelson MD, McKay RR, Werner L, Atkins MB, Van Allen EM, Olivier KM, Song J, Signoretti S, McDermott DF, Choueiri TK.Cancer. 2015 Oct 1;121(19):3435-43. [Epub 2015 Jun 8]. doi: 10.1002/cncr.29503. [electronic resource] by
- Jay, Raman
- McKay, R R
- Werner, L
- Atkins, M B
- Van Allen, E M
- Olivier, K M
- Song, J
- Signoretti, S
- McDermott, D F
- Choueiri, T K
Producer: 20190318
In:
Urologic oncology vol. 35
Availability: No items available.
|
|
|
23.
|
|
|
|
24.
|
|
|
|
25.
|
|
|
|
26.
|
|
|
|
27.
|
|
|
|
28.
|
|
|
|
29.
|
|
|
|
30.
|
|
|
|
31.
|
|
|
|
32.
|
|
|
|
33.
|
|
|
|
34.
|
|
|
|
35.
|
|
|
|
36.
|
|
|
|
37.
|
|
|
|
38.
|
|
|
|
39.
|
|
|
|
40.
|
|